Clinical Trial Update: Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing EC-T versus PCb as adjuvant chemotherapy for non-triple-negative breast cancer; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING